MedPath

The Visceral Analgesic Effect of Erector Spinae Plane Block in Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Visceral Pain, Postoperative
Interventions
Drug: Ultrasound guided Rectus sheath block
Drug: Ultrasound erector spinae plane block
Registration Number
NCT03767816
Lead Sponsor
Asan Medical Center
Brief Summary

The purpose of this study was to investigate the effectiveness of erector spinae plane block on postoperative visceral pain in laparoscopic cholecystectomy (LLC). Given that rectus sheath block may provide sufficient somatic pain block, investigators aimed to investigate whether erector spinae block is effective in visceral pain block.

After induction of general anesthesia, group of patient is decided randomly. In Group R, rectus sheath block is performed with 0.2% Ropivacaine 30ml before the operation. In Group RE, rectus sheath block and erector spinae plane block are performed with 0.2% ropivacaine 70ml before the operation.

NRS score measurement and comparison of the rescue analgesic dose used at 0, 0.5, 1, 2,6, 12, 18, and 24 hours after arrival at the recovery room were collected

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. adults between the ages of 20 and 80
  2. scheduled laparoscopic cholecystectomy patient
  3. American society of anesthesiologists score 1 or 2
  4. Patients who have voluntarily agreed in writing to participate in the trial
Read More
Exclusion Criteria
  1. Patient with side effects on local anesthetics or steroids
  2. Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc.
  3. Patients with uncontrolled medical or psychiatric problem
  4. Patient does not agree to participate in the study
  5. Patients with deformity at vertebra or chest wall.
  6. Patients who are pregnant or lactating
  7. Patients receiving a single laparoscopic cholecystectomy (including using a robot)
  8. Patients with severe intraperitoneal adhesion (higher than Nair s grade 3), or with external drain.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group RE: Rectus sheath block and erector spinae plane blockUltrasound erector spinae plane blockultrasound guided Rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml before surgical incision and ultrasound guided erector spinae plane block with 0.2% ropivacaine (Fresenius Kabi) 40ml
Group RE: Rectus sheath block and erector spinae plane blockUltrasound guided Rectus sheath blockultrasound guided Rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml before surgical incision and ultrasound guided erector spinae plane block with 0.2% ropivacaine (Fresenius Kabi) 40ml
Group R : Rectus sheath block groupUltrasound guided Rectus sheath blockultrasound guided Rectus sheath block with 0.2% ropivacaine (Fresenius Kabi) 30ml before surgical incision
Primary Outcome Measures
NameTimeMethod
Difference of analgesic consumption between both groupat 0, 0.5, 1, 2, 6, 12, 18, 24 hours after operation

The difference in analgesics usage between the two groups after the operation is checked at fixed intervals (at 0, 0.5,

1, 2, 6, 12, 18, 24 hours after operation) to compare.

Secondary Outcome Measures
NameTimeMethod
compare the Numeric rating scale (NRS)at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation

10 years old or older. 0: No pain, 1-3: mild pain, 4-6: Moderate pain, 7-10: severe pain, 10: worst pain imaginable.

After surgery, the NRS differences between the two groups were compared at a constant interval (0, 0.5, 1, 2, 6, 12, 18, 24 hours postoperatively).

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Songpa-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath